e-learning
resources
Madrid 2019
Tuesday, 01.10.2019
Research and innovation in airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Surfactant Protein A in Particles in Exhaled Air and serum
H. Koca Akdeve (Gothenburg, Sweden)
Source:
International Congress 2019 – Research and innovation in airway diseases
Session:
Research and innovation in airway diseases
Session type:
Thematic Poster
Number:
4273
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Koca Akdeve (Gothenburg, Sweden). Surfactant Protein A in Particles in Exhaled Air and serum. 4273
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Static lung volumes and spirometry measurements
Panel discussion: The role of pharmacotherapy connected to OSA pathophysiological traits
Expert interview ERS guideline on non-CPAP therapies in obstructive sleep apnoea
Related content which might interest you:
Pattern of phospholipids and Surfactant Protein A in Particles in Exhaled Air (PExA)
Source: International Congress 2017 – Techniques in biomarker selection
Year: 2017
Exhaled surfactant protein A and albumin in a healthy Swedish population
Source: International Congress 2016 – Airway biomarkers
Year: 2016
MCC-IMS Analyses of Volatile Markers from Exhaled Air for Detection of Bacterial Infection between nasal suction and exhalation through Mouth
Source: International Congress 2019 – Evaluation of basic science in airway diseases
Year: 2019
Comparison of Fractional Nitric Oxide in Exhaled Breath in bronchial asthma and COPD
Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers
Year: 2017
Correlation between Blood Eosinophilia and Fractional Exhaled Nitric Oxide in the diagnosis of Asthma within Primary Care.
Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling
Year: 2020
Can Exhaled Nitric Oxide Be a Biomarker for Hospitalized and Post-COVID-19 Patients?
Source: Virtual Congress 2021 – Biological and functional markers of COVID-19
Year: 2021
Exhaled gases
Source: Annual Congress 2009 - PG8 Asthma: monitoring airway disease
Year: 2009
Does Exhaled Nitric Oxide Correlate with Established Measures of Asthma Severity?
Source: International Congress 2018 – Biomarkers for evaluating asthma
Year: 2018
Indoor Air Freshener Extract Increases Pneumococcal Adhesion to Airway Cells
Source: International Congress 2019 – Indoor and outdoor air quality considerations
Year: 2019
ATS/ERS Recommendations for Standardized Procedures for the Online and Offline Measurement of Exhaled Lower Respiratory Nitric Oxide and Nasal Nitric Oxide
Source: Guideline 2005
Year: 2005
Exhaled NO and other gases as biomarkers
Source: Annual Congress 2003 - PG18 - Markers of inflammation in obstructive airway disease
Year: 2003
Exhaled Breath Biomarkers in Sarcoidosis: A Systematic Review
Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management
Year: 2018
Ozone and Sensitization Alter Airway and Nerve-associated Eosinophils
Source: International Congress 2017 – Animal models of asthma and allergies
Year: 2017
Exhaled air analysis
Source: International Congress 2016 – New tools for the early diagnosis of acute respiratory distress syndrome
Year: 2016
Exhaled Breath Analysis for Prediction of Response to Anti-PD1 Therapy in Patients with NSCLC
Source: International Congress 2017 – Lung cancer: clinical research on exhaled breath, clinical trials in advanced NSCLC and real-life appraisals of immunotherapies
Year: 2017
Surfactant protein A in particles in exhaled air (PEx) – A better reflection of small airways in comparison to bronchoalveolar lavage and serum?
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013
Effects of Intrauterine Exposure to Concentrated Ambient Particles on Mice Offspring Sensitized with House Dust Mite
Source: International Congress 2017 – Air pollution
Year: 2017
Iron Oxide and Titanium Dioxide Nanoparticles Reduce Alveolar Epithelial Cell Stiffening and Contraction Forces
Source: International Congress 2018 – COPD: novel pathological mechanisms in the airway epithelium
Year: 2018
Exhaled Volatile Organic Compounds are Able to Diagnose Systemic Sclerosis
Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept